| Tag | Content |
|---|
EnhancerAtlas ID | HS192-13708 |
Organism | Homo sapiens |
Tissue/cell | U2OS |
Coordinate | chr8:144876130-144877200 |
Target genes | | Number: 51 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| RREB1 | MA0073.1 | chr8:144876655-144876675 | CCCCTCACCACCACCCCACC | + | 6.73 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_25185 | chr8:144876686-144877671 | Colon_Crypt_3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH08I143792 | chr8 | 144874771 | 144876721 |
|
Enhancer Sequence | ACCTGGAGGA GTAGGCAGTG GGTGGGGTGA GGATGGGCAG GGCTGTGGCC CCCGACCAGG 60
AGGGACTGGG GGCCCTGGGG CTTGCCTAAA AGCCACAGCA GCTCTTCAGT TCCCCAACCT 120
GACTATAGCC CAGGGGATGC CCCAGACACT CGGTCAGCAC GGAGGGGCTC GTCCCCGTTC 180
CCACAGGATG CGGGGGCCTG GGCTGGGCAG CTGCTGTCTC CATGGCAGTG TGCTGGCTGG 240
AGCTTTGCAG GAGAGATGGG AGCAGACAGG ACAGCCGGAG AAGAGAGCAG GGAGGGCTCG 300
GGGGAGGGGC CAGAGACAGA GGTGATGGTG GGGAGCCCCT ACTTGTGGTG TGCAGCCCTC 360
AGGGCTCAGT GGCGCCCTGA CTGCTGCCCC CATGACTGTG CTGTTGTTCA TGAGGATGAA 420
GGGCCTCCCG GAAGCCTCCC TCTTGGCGCT GCCCATGGCC AGAGGAGGCA GGGTCAGTAC 480
CCAAGAGCCC CCGAATGCGC TGCCTCAGAT CCAGGCCCTG CCTGGCCCCT CACCACCACC 540
CCACCGCTTG GGCAAGGGCC TGCAGGAGCC ACCCCTCGGC ACTCACGTTC GGTGGGGCTG 600
GTGGGGCGCA CCCTCTGGGA GGGTTATTTG TATCTCTAAG GGGAGGGATG GGCCTGCACA 660
TCCTCCTGCC TGTCCCCAGC ACCCGCCCCT CCAGCTGCTC CAGCCTGTCC TCCCCTTGGG 720
GACATGTGCC TGCCCAATCC CCCAGGAGCC TCTGCCCCCA CTCGCACCCT CTGGGGCTGG 780
GCAGCCCCAG CAGCAGCAGG TGAAGCTCTC GCACCGCCAC TAGAGGGATG CCTCGGCCTG 840
TGTCACCCAT CCGCAGCTCA GGGTGTGTGG GTGGGGCAGC ACCAACATGG CTTGGGTTGA 900
GAATGAGGGT GATAAGCATG TGCCAGGCTG GGGTAGCCTG CAGGTCAGAC GTGGCCTCCT 960
CCCACCCCAG CCCCCGCCCA AAGGTTCCCT CCCGGATGGC CCTGGCGTTT GTCCTGGGGT 1020
GGCCGATGAA CAGGACAACA GGACGGAGGT GGGGGGCACT GCACACTGGG 1070
|
